Reports for HYDROCHLOROTHIAZIDE
Ingredient
HYDROCHLOROTHIAZIDE
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CANDESARTAN-HCTZ | 12.5MG 16.0MG | TABLET | Actual shortage | 2024-05-03 | 2024-05-04 | 227037 |
| CANDESARTAN/HCTZ | 12.5MG 16MG | TABLET | Actual shortage | 2024-04-22 | 2024-04-23 | 225881 |
| TEVA-TELMISARTAN HCTZ | 25.0MG 80.0MG | TABLET | Actual shortage | 2024-04-11 | 2024-05-03 | 224901 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Actual shortage | 2024-04-11 | 2024-04-18 | 224898 |
| TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Actual shortage | 2024-04-11 | 2024-04-11 | 224895 |
| SANDOZ LISINOPRIL HCT | 25MG 20MG | TABLET | Actual shortage | 2024-04-08 | 2024-04-09 | 224639 |
| OLMESARTAN/HCTZ | 20MG 12.5MG | TABLET | Anticipated shortage | 2024-03-26 | 2024-03-26 | 223386 |
| OLMESARTAN/HCTZ | 40MG 12.5MG | TABLET | Anticipated shortage | 2024-03-26 | 2024-03-26 | 223383 |
| OLMESARTAN/HCTZ | 40MG 25MG | TABLET | Anticipated shortage | 2024-03-26 | 2024-03-26 | 223370 |
| APO-HYDROCHLOROTHIAZIDE | 12.5MG | TABLET | Resolved | 2024-03-22 | 2024-04-26 | 223083 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LISINOPRIL/HCTZ | 12.5MG 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1093 |
| APO-LISINOPRIL/HCTZ | 12.5MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1090 |